Nirdosh Kumar Gogna

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial

James W. Denham, David Joseph, David S. Lamb et al. · The Lancet Oncology · 2014 · 159 citations

Zoledronic Acid, Urology, Trog 03.04 +6

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

James W. Denham, David Joseph, David S. Lamb et al. · The Lancet Oncology · 2018 · 105 citations

Zoledronic Acid, Urology, Radiation Medicine +7

Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: A report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group

Nirdosh Kumar Gogna, J. H. Matthews, Sandra Turner et al. · Radiotherapy and Oncology · 2006 · 69 citations

Urology, Radiation Medicine, Radiation Therapy +6

Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial

David Joseph, James W. Denham, Allison Steigler et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 63 citations · Full text

Urology, Radiation Medicine, Trog 03.04 +8

Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial

James W. Denham, Allison Steigler, David Joseph et al. · Radiotherapy and Oncology · 2015 · 55 citations

Urology, Trog 03.04, Radiation Therapy +7